NCT05491070View on ClinicalTrials.gov

Comparison of Different Vascular Closure Device in TAVI

NACompletedINTERVENTIONAL
Enrollment

260

Participants

Timeline

Start Date

March 20, 2018

Primary Completion Date

April 13, 2023

Study Completion Date

April 30, 2024

Conditions
Aortic Valve StenosisTranscatheter Aortic Valve Implantation
Interventions
DEVICE

Vascular closure device (Angio-Seal, Progilde)

In transfemoral TAVI, vascular closure devices were used for femoral artery wound closure, progilde and angio-seal can be used in wound closure. We aimed to compared the efficacy and safety of different vascular closure device in TAVI

Trial Locations (1)

100

National Taiwan University Hospital, Taipei

All Listed Sponsors
lead

National Taiwan University Hospital

OTHER

NCT05491070 - Comparison of Different Vascular Closure Device in TAVI | Biotech Hunter | Biotech Hunter